Conbercept for Treatment of Neovascular Age-Related Macular Degeneration and Visual Impairment due to Diabetic Macular Edema or Pathologic Myopia Choroidal Neovascularization: A Systematic Review and Meta-Analysis

Background: Conbercept is a new anti-vascular endothelial growth factor (VEGF) drug. Here, we systematically conducted the efficacy, safety, compliance, and pharmacoeconomic evaluation of intravitreal conbercept (IVC) compared with other treatments in patients with neovascular age-related macular de...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Pengxiang, Zheng, Siqian, Wang, Ente, Men, Peng, Zhai, Suodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546330/
https://www.ncbi.nlm.nih.gov/pubmed/34712132
http://dx.doi.org/10.3389/fphar.2021.696201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546330/
https://www.ncbi.nlm.nih.gov/pubmed/34712132
http://dx.doi.org/10.3389/fphar.2021.696201

Ejemplares similares